The Nevada National Board Professional Learning Institute | Ziegler | Activity http://www.nationalboardinstitute.com/members/moneyangle52/activity/ Activity feed for Ziegler. Fri, 23 May 2025 17:06:54 -0700 https://buddypress.org/?v=9.1.1 en-US 30 hourly 2 4fc0cff80246c8a348ebccb5c56252e5 Ziegler posted an update: PR-PFD restored levels of insulin, glucagon, adiponectin, […] http://www.nationalboardinstitute.com/activity/p/41604/ Sat, 08 Feb 2025 09:51:46 -0800 PR-PFD restored levels of insulin, glucagon, adiponectin, and resistin along with improved insulin resistance. Noteworthy, SIRT1-liver kinase B1-phospho-5′ adenosine monophosphate-activated protein kinase signaling and the PPAR-α/carnitine O-palmitoyltransferase 1/acyl-CoA oxidase 1 pathway were clearly induced in high fat + PR-PFD mice. In HepG2…[Read more]

]]> 0 b999a7d7d69cf89d7e8007b1bfff8261 Ziegler posted an update: 62; 95% CI 0.18-2.15; p = 0.447). In the network m […] http://www.nationalboardinstitute.com/activity/p/39828/ Thu, 06 Feb 2025 10:22:49 -0800 62; 95% CI 0.18-2.15; p = 0.447). In the network meta-analysis, no significant difference was found among the four different prophylaxes. Our findings suggested that, when compared with the short-term use, the long-term use of prophylactic AEDs in SAH patients has a similar effect on in-hospital seizure prevention but is associated with poor c…[Read more]

]]> 0 1a0467230a2ca639424c8f48ea392da4 Ziegler posted an update: It needs to be tailored to the patient's functional status, […] http://www.nationalboardinstitute.com/activity/p/35485/ Sat, 01 Feb 2025 09:43:28 -0800 It needs to be tailored to the patient’s functional status, comorbid diseases, prognosis, and response to conservative management.Background To account for cancer heterogeneity, we previously introduced the concept of “personalized” tumor markers, which are biomarkers that are informative in subsets of patients or even a single patient. RMC-4550…[Read more]

]]> 0 94b33bb956b0756d02d7371ae90c8f9f Ziegler posted an update: Larger intracoronary thrombus burden correlates with greater […] http://www.nationalboardinstitute.com/activity/p/33538/ Thu, 30 Jan 2025 09:43:48 -0800 Larger intracoronary thrombus burden correlates with greater infarct size, distal embolization, and the associated no-reflow phenomena, and propagates stent thrombosis, with subsequent increase in mortality and major adverse cardiac events. Intracoronary thrombolysis may provide useful adjunct therapy in highly selected STEMI cases to reduce…[Read more]

]]> 0 30160ffb8abc69ff01c0f73e8180ffb6 Ziegler posted an update: ciated with a higher rate of adverse events. In our cases it […] http://www.nationalboardinstitute.com/activity/p/30095/ Tue, 28 Jan 2025 14:42:49 -0800 ciated with a higher rate of adverse events. In our cases it was possible to control the immune response by close monitoring and adaptation of the immunosuppressive regimen. Further research is needed to better understand the immune response following gene therapy and ideally to identify patients at risk for a more severe reaction.

Attentional…[Read more]

]]> 0 ae3b76e431a2d7d3497f23ad3b7f0cfe Ziegler became a registered member http://www.nationalboardinstitute.com/activity/p/30066/ Tue, 28 Jan 2025 14:40:15 -0800 0